Home » Topics » BioWorld Science

BioWorld Science
RSS

IKZF1 gain-of-function variants tied to T/B cell-related immune dysregulation

April 7, 2022

Emergex collaborates with nonprofit organization to advance yellow fever booster vaccine candidate

April 7, 2022

New TYK2 inhibitors identified by Esker Therapeutics

April 7, 2022

Merck & Co. synthesizes new GLCT-1 inhibitors

April 7, 2022

Aurigene Discovery Technologies presents CREBBP and/or KAT3B inhibitors

April 7, 2022

Sunshine Lake Pharma discloses thyroid hormone receptor beta agonists

April 7, 2022

Medshine Discovery patents new sGC activators

April 7, 2022

Peptidomimetic TMPRSS2 inhibitor shows prophylactic and therapeutic activity against SARS-CoV-2 VOCs

April 7, 2022

T cell-intrinsic AR activity drives IFN-gamma suppression and immunotherapy resistance

April 7, 2022

Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022

April 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...